# Dianthus Therapeutics, Inc.: Form SC 13D/A, filed Feb 17, 2021

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: SC 13D/A
- Filed: 2021-02-17
- Accepted by EDGAR: Feb 17, 2021, 08:26 ET
- Period: not reported
- Accession: 0001387131-21-002579
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000138713121002579/magenta-sc13da_021121.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000138713121002579/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000138713121002579/magenta-sc13da_021121.htm

Filed Feb 17, 2021.
Source: SEC EDGAR, the filing index for accession 0001387131-21-002579. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.